Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Geoffrey Raymond Oxnard currently holds 61,783 shares of BlossomHill Therapeutics, Inc. (BLSM), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Geoffrey Raymond Oxnard has been a net neutral trader of BLSM stock. They have purchased $0 and sold $0 worth of shares.
Geoffrey Raymond Oxnard's most recent insider trade was on Aug 6, 2026, when they sold 61,783 shares at $0.00 per share.
Geoffrey Raymond Oxnard serves as Chief Medical Officer at BlossomHill Therapeutics, Inc. (BLSM). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Geoffrey Raymond Oxnard holds the position of Chief Medical Officer at BlossomHill Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Geoffrey Raymond Oxnard has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Geoffrey Raymond Oxnard was on Aug 6, 2026, when they purchased $0 worth of BLSM shares. This transaction involved 61,783 shares at N/A per share.
Geoffrey Raymond Oxnard currently owns 61,783 shares of BlossomHill Therapeutics, Inc. (BLSM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Geoffrey Raymond Oxnard's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Geoffrey Raymond Oxnard has 1 Form 4 filings on record as an insider at BlossomHill Therapeutics, Inc..
Set alerts for Geoffrey Raymond Oxnard and 40,000+ other insiders.